Literature DB >> 16998536

Regulating insulin signaling and beta-cell function through IRS proteins.

Morris F White1.   

Abstract

Diabetes mellitus is a complex disorder that arises from various causes, including dysregulated glucose sensing and impaired insulin secretion (maturity onset diabetes of youth, MODY), autoimmune-mediated beta-cell destruction (type 1), or insufficient compensation for peripheral insulin resistance (type 2). Type 2 diabetes is the most prevalent form that usually occurs at middle age; it afflicts more than 30 million people over the age of 65, but is appearing with greater frequency in children and adolescents. Dysregulated insulin signaling exacerbated by chronic hyperglycemia promotes a cohort of systemic disorders--including dyslipidemia, hypertension, cardiovascular disease, and female infertility. Understanding the molecular basis of insulin resistance can prevent these disorders and their inevitable progression to type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16998536     DOI: 10.1139/y06-008

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  72 in total

1.  Insulin receptor substrate 2 (IRS2)-deficient mice show sensorineural hearing loss that is delayed by concomitant protein tyrosine phosphatase 1B (PTP1B) loss of function.

Authors:  Silvia Murillo-Cuesta; Guadalupe Camarero; Agueda González-Rodríguez; Lourdes Rodríguez De La Rosa; Deborah J Burks; Carlos Avendaño; Angela M Valverde; Isabel Varela-Nieto
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

2.  Metabolic stress signaling mediated by mixed-lineage kinases.

Authors:  Anja Jaeschke; Roger J Davis
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

3.  Insulin stimulates primary beta-cell proliferation via Raf-1 kinase.

Authors:  Jennifer L Beith; Emilyn U Alejandro; James D Johnson
Journal:  Endocrinology       Date:  2008-01-17       Impact factor: 4.736

4.  Signal transduction cross talk mediated by Jun N-terminal kinase-interacting protein and insulin receptor substrate scaffold protein complexes.

Authors:  Claire L Standen; Norman J Kennedy; Richard A Flavell; Roger J Davis
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

Review 5.  Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes.

Authors:  Katrina MacAulay; James R Woodgett
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

6.  Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.

Authors:  Jaetaek Kim; Adam R Wende; Sandra Sena; Heather A Theobald; Jamie Soto; Crystal Sloan; Benjamin E Wayment; Sheldon E Litwin; Martin Holzenberger; Derek LeRoith; E Dale Abel
Journal:  Mol Endocrinol       Date:  2008-09-18

7.  Angiotensin II shifts insulin signaling into vascular remodeling from glucose metabolism in vascular smooth muscle cells.

Authors:  Hirofumi Hitomi; Kumiko Kaifu; Yoshiko Fujita; Tadashi Sofue; Daisuke Nakano; Kumiko Moriwaki; Taiga Hara; Hideyasu Kiyomoto; Masakazu Kohno; Hiroyuki Kobori; Akira Nishiyama
Journal:  Am J Hypertens       Date:  2011-06-30       Impact factor: 2.689

Review 8.  The nuts and bolts of AGC protein kinases.

Authors:  Laura R Pearce; David Komander; Dario R Alessi
Journal:  Nat Rev Mol Cell Biol       Date:  2010-01       Impact factor: 94.444

Review 9.  Growth factor control of pancreatic islet regeneration and function.

Authors:  Anke Assmann; Charlotte Hinault; Rohit N Kulkarni
Journal:  Pediatr Diabetes       Date:  2008-09-19       Impact factor: 4.866

10.  Insulin receptor substrate-2 regulates aerobic glycolysis in mouse mammary tumor cells via glucose transporter 1.

Authors:  Shannon L Pankratz; Ernest Y Tan; Yumiko Fine; Arthur M Mercurio; Leslie M Shaw
Journal:  J Biol Chem       Date:  2008-12-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.